A cholecystokinin B receptor antagonist and cocaine interaction, phase I study-Reference-Cited by-同舟云学术

A cholecystokinin B receptor antagonist and cocaine interaction, phase I study

Published:2018-06-20 Issue:1 Volume:25 Page:136-146
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Elkashef Ahmed¹^ORCID,Brašić James Robert²,Cantelina Louis R.³,Kahn Roberta¹,Chiang Nora¹,Ye Weiguo²,Zhou Yun²,Mojsiak Jurij¹,Warren Kimberly R.⁴,Crabb Andrew²,Hilton John²,Wong Dean F.²⁵⁶⁷⁸,Vocci Frank¹⁹

Affiliation:

1. Medications Development Division The National Institute on Drug Abuse National Institutes of Health Bethesda MD USA

2. Section of High Resolution Brain Positron Emission Tomography Imaging Division of Nuclear Medicine and Molecular Imaging The Russell H. Morgan Department of Radiology and Radiological Science School of Medicine Johns Hopkins University Baltimore MD USA

3. Division of Clinical Pharmacology and Medical Toxicology Uniformed Services University of the Health Sciences Bethesda MD USA

4. Department of Psychology Morgan State University Baltimore MD USA

5. Department of Psychiatry and Behavioral Sciences Baltimore MD USA

6. Department of Neurology Baltimore MD USA

7. Soloman H Snyder Department of Neurosciences Baltimore MD USA

8. Department of Environmental Health and Engineering Bloomberg School of Public Health Baltimore MD USA

9. Friends Research Institute Baltimore MD USA

Funder

National Institute on Drug Abuse

Uniformed Services University of the Health Sciences

Johns Hopkins University

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.12994

Reference49 articles.

1. U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA). June 2016.Cocaine.https://www.drugabuse.gov/drugs-abuse/cocaine. Accessed June 4 2018.

2. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway

3. Evidence for coexistence of dopamine and CCK in meso-limbic neurones

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal microbiome dysbiosis in alcohol-dependent patients and its effect on rat behaviors;mBio;2023-12-19

2. Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction;Addiction Neuroscience;2022-09

3. Inhibition of Geranylgeranylacetone on cholecystokinin-B receptor, BDNF and dopamine D1 receptor induced by morphine;Biochemical and Biophysical Research Communications;2022-01

4. Medications development for food-based and drug use disorders;Advances in Pharmacology;2019